A Probody™ Drug Conjugate Targeting CD166 (ALCAM) Enhances Preclinical Antitumor Activity of a Probody Therapeutic Targeting PD-1

Erwan Le Scolan, Tiffany Tse, Michael Krimm, Will Garner, Hikmat Assi, Jennifer Razo, Laurie Wong, Kenneth R. Wong, Victoria Singson, Jennifer Leong, Linnea Diep, Jennifer H. Richardson, Siew Schleyer, Dylan Daniel, Marcia Belvin, W. Michael Kavanaugh. Poster presented at AACR 2019, March 29-April 3, Atlanta, Georgia